These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cardiovascular risk and rheumatoid arthritis: from mechanisms of atherosclerosis to therapeutic approach. Jurcuţ C; Jurcuţ R; Tănăsescu C Rom J Intern Med; 2004; 42(4):659-69. PubMed ID: 16366138 [TBL] [Abstract][Full Text] [Related]
4. Role of inflammation in atherosclerosis associated with rheumatoid arthritis. Libby P Am J Med; 2008 Oct; 121(10 Suppl 1):S21-31. PubMed ID: 18926166 [TBL] [Abstract][Full Text] [Related]
5. Inflammation: a pivotal link between autoimmune diseases and atherosclerosis. Abou-Raya A; Abou-Raya S Autoimmun Rev; 2006 May; 5(5):331-7. PubMed ID: 16782558 [TBL] [Abstract][Full Text] [Related]
6. Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity. Kerekes G; Szekanecz Z; Dér H; Sándor Z; Lakos G; Muszbek L; Csipö I; Sipka S; Seres I; Paragh G; Kappelmayer J; Szomják E; Veres K; Szegedi G; Shoenfeld Y; Soltész P J Rheumatol; 2008 Mar; 35(3):398-406. PubMed ID: 18203326 [TBL] [Abstract][Full Text] [Related]
7. How early is the atherosclerotic risk in rheumatoid arthritis? Bartoloni E; Alunno A; Bistoni O; Gerli R Autoimmun Rev; 2010 Aug; 9(10):701-7. PubMed ID: 20542146 [TBL] [Abstract][Full Text] [Related]
8. Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis. Montecucco F; Mach F Rheumatology (Oxford); 2009 Jan; 48(1):11-22. PubMed ID: 18927189 [TBL] [Abstract][Full Text] [Related]
9. C-reactive protein in atherosclerosis: A causal factor? Paffen E; DeMaat MP Cardiovasc Res; 2006 Jul; 71(1):30-9. PubMed ID: 16624260 [TBL] [Abstract][Full Text] [Related]
10. Chronic inflammatory autoimmune disorders and atherosclerosis. Abou-Raya S; Abou-Raya A; Naim A; Abuelkheir H Ann N Y Acad Sci; 2007 Jun; 1107():56-67. PubMed ID: 17804533 [TBL] [Abstract][Full Text] [Related]
11. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy. Mäki-Petäjä KM; Hall FC; Booth AD; Wallace SM; Yasmin ; Bearcroft PW; Harish S; Furlong A; McEniery CM; Brown J; Wilkinson IB Circulation; 2006 Sep; 114(11):1185-92. PubMed ID: 16952987 [TBL] [Abstract][Full Text] [Related]
12. Assessment of inflammatory markers and endothelial function. Järvisalo MJ; Juonala M; Raitakari OT Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):547-52. PubMed ID: 16912549 [TBL] [Abstract][Full Text] [Related]
13. Atherosclerotic vascular damage and rheumatoid arthritis: a complex but intriguing link. Bartoloni E; Alunno A; Luccioli F; Moscatelli S; Biscontini D; Santoboni G; Gerli R Expert Rev Cardiovasc Ther; 2010 Sep; 8(9):1309-16. PubMed ID: 20828353 [TBL] [Abstract][Full Text] [Related]
14. Atherogenesis in rheumatoid arthritis: the "rheumatoid vasculopathy"? Fietta P; Delsante G Acta Biomed; 2009; 80(3):177-86. PubMed ID: 20578409 [TBL] [Abstract][Full Text] [Related]
15. Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms. Loppnow H; Werdan K; Buerke M Innate Immun; 2008 Apr; 14(2):63-87. PubMed ID: 18713724 [TBL] [Abstract][Full Text] [Related]
16. Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs. Avouac J; Allanore Y Expert Opin Pharmacother; 2008 May; 9(7):1121-8. PubMed ID: 18422470 [TBL] [Abstract][Full Text] [Related]